COMMUNIQUÉS West-GlobeNewswire

Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings
21/11/2024
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Aeroflow Health Celebrates Nevada’s Elimination of the Diaper Tax
21/11/2024
Through its ongoing advocacy efforts, Aeroflow supported the passing of SB 428 to alleviate the financial burden a diaper tax can impose on families in the state of Nevada ASHEVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE [...]
Gaurav Agarwal Joins Capsa Healthcare as Chief Executive Officer to Lead Next Innovative Growth Phase
21/11/2024
Healthcare Solutions Leader Welcomes Experienced Executive To Drive Key Strategic Initiatives COLUMBUS, Ohio, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare , a leader in advanced healthcare workflow and pharmacy [...]
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21/11/2024
Funding supports the technology’s transition from academic to clinical use BOSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- DANNCE.AI raised $2.6 million in pre-seed funding led by LDV Capital, following initial investment [...]
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
21/11/2024
- Poster presentations on BMB-101 will focus on 5-HT 2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company [...]
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action
21/11/2024
AUSTIN, Texas, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that new analyses of data from its Phase [...]
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
21/11/2024
– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique design of potent and selective macrocycles for therapeutic [...]
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
21/11/2024
SAN MATEO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral hepatitis and other serious liver diseases, [...]
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024
21/11/2024
LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
21/11/2024
Workshop, poster and oral presentation of data given as part of the 8 th Annual Antifibrotic Drug Development (AFDD) Summit Data demonstrate that NKT cells are activated in airways in IPF patients and inhibition of iNKT [...]
Cidara Therapeutics Announces $105 Million Private Placement
21/11/2024
Financing led by new investor, Venrock Healthcare Capital Partners, with significant participation by new and existing life sciences-focused investors SAN DIEGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, [...]
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
21/11/2024
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global [...]
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
21/11/2024
Acquiring and Developing Services and Resources to Build a Full Service, Customer-Focused CRO has Fueled 847% Revenue Growth WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 138 [...]
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
21/11/2024
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
21/11/2024
Expands accessibility for institutions utilizing GE HealthCare MRI systems DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage [...]
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
21/11/2024
New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), and Ulcerative Colitis ($1.9 billion+) The company received three notices [...]
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC)
21/11/2024
Data to be presented at the 8 th Annual Antifibrotic Drug Development (AFDD) Summit PALI-2108 may offer a solution for fibrostenotic Crohn’s disease by enhancing efficacy, safety, and therapeutic potential compared to [...]
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors
21/11/2024
SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR T-cells, today announced [...]
Acies Bio and Protein Evolution Announce Strategic Partnership to Advance Biological Recycling Technology
21/11/2024
LJUBLJANA, Slovenia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Protein Evolution , a pioneer in enzyme-driven plastics recycling, has announced a collaboration with Acies Bio , an innovative biotechnology company specializing [...]

Pages